Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-01-03 @ 10:13 PM
Study NCT ID:
NCT00482703
Status:
COMPLETED
Last Update Posted:
2010-12-17
First Post:
2007-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-04
First Submit QC Date:
None
Study First Post Date:
2007-06-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-07-23
Results First Submit QC Date:
None
Results First Post Date:
2010-11-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-11-30
Last Update Post Date:
2010-12-17
Last Update Post Date Type:
ESTIMATED